Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

background of header
foreground of header
  • Newsletter
Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it
Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it
Wed, Jul 8th 2026
Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs 
Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs 
Wed, Jul 1st 2026
CVS Health executives on reducing healthcare's biggest pain points
CVS Health executives on reducing healthcare's biggest pain points
Thu, Jun 11th 2026
Trump officials hit California with Medicaid funding freeze
Trump officials hit California with Medicaid funding freeze
Wed, May 27th 2026
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know
Wed, May 27th 2026
Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients
Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients
Tue, May 12th 2026
Healthy Returns: Novo Nordisk faces Ozempic generics in Canada
Healthy Returns: Novo Nordisk faces Ozempic generics in Canada
Thu, May 7th 2026
FOLLOW
Twitter IconA Twitter icon
About

Top health care investors, CEOs and technologists explore the innovations that will drive better outcomes, financially and clinically. For more exclusive insights from our reporters and speakers, sign up for our Healthy Returns newsletter to get the latest delivered straight to your inbox weekly.

More in Healthy Returns

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says
Annika Kim ConstantinoWed, Mar 18th 2026
Healthy Returns: What’s next for Novo Nordisk’s next-generation obesity drug after trial miss
Annika Kim ConstantinoTue, Feb 24th 2026
Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China
Annika Kim ConstantinoThu, Feb 19th 2026
Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data
Annika Kim ConstantinoFri, Feb 6th 2026
Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations
Annika Kim ConstantinoWed, Jan 28th 2026
Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s
Annika Kim ConstantinoWed, Jan 21st 2026
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Annika Kim ConstantinoFri, Jan 16th 2026
Healthy Returns: What to expect from pharma at the JPM conference
Annika Kim ConstantinoFri, Jan 9th 2026
Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly
Annika Kim ConstantinoTue, Dec 16th 2025
Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know
Annika Kim ConstantinoFri, Dec 12th 2025
Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data
Annika Kim Constantino|Bertha CoombsWed, Nov 12th 2025
Healthy Returns: What to know about Pfizer, Novo Nordisk’s bidding war over obesity biotech Metsera
Annika Kim Constantino|Bertha CoombsWed, Nov 5th 2025
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings
Annika Kim ConstantinoTue, Oct 28th 2025
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill
Annika Kim Constantino|Bertha CoombsTue, Oct 21st 2025
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
Annika Kim Constantino|Bertha CoombsTue, Oct 7th 2025
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Annika Kim Constantino|Bertha CoombsTue, Sep 30th 2025
Healthy Returns: What to know about RFK Jr.'s five new vaccine panel members
Annika Kim Constantino|Ashley CapootWed, Sep 17th 2025
Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to latest Watch
Annika Kim Constantino|Ashley CapootWed, Sep 10th 2025
Healthy Returns: Novo Nordisk’s head of research and development previews the first obesity pill
Annika Kim Constantino|Ashley CapootWed, Sep 3rd 2025
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Annika Kim Constantino|Bertha CoombsTue, Aug 26th 2025
Healthy Returns: New study casts doubts on RFK Jr.'s reasons for gutting key vaccine panel
Annika Kim Constantino|Bertha CoombsTue, Aug 19th 2025
Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites 
Annika Kim Constantino|Ashley CapootWed, Aug 13th 2025
Healthy Returns: Medicare, Medicaid to reportedly pilot covering obesity drugs in win for drugmakers
Annika Kim Constantino|Ashley CapootTue, Aug 5th 2025
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
Annika Kim Constantino|Ashley CapootWed, Jul 30th 2025
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • Join the CNBC Panel
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo